Moderna studies two booster candidates to anticipate new variant-like mutations
Washington, Nov. 27 -- American pharma company Moderna said on Friday it is studying two booster candidates designed to anticipate mutations similar to the Omicron COVID-19 variant discovered in South Africa this week.
"Moderna is already studying two multi-valent booster candidates in the clinic that were designed to anticipate mutations such as those that have emerged in the Omicron variant," the company said in a statement.
The new variant-B.1.1.52-was first detected in southern Africa.
This mutant variant has led to a surge in infections in South Africa and other countries in the southern part of the continent.
Published by HT Digital Content Services with permission from India Blooms....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.